Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
March 05 2024 - 7:00AM
Business Wire
Company to Host Conference Call to Discuss
Results at 8:00 a.m. ET on March 20, 2024
Harrow (Nasdaq: HROW), a leading North American eyecare
pharmaceutical company, today announced that it will release its
financial results for the fourth quarter and year ended December
31, 2023, on Tuesday, March 19, 2024, after the market close. The
Company will also post its fourth quarter Letter to Stockholders to
the “Investors” section of its website, harrow.com. Harrow will
host a conference call and live webcast at 8:00 a.m. Eastern Time
on Wednesday, March 20, 2024, to discuss the results and provide a
business update.
Conference Call Details:
Date:
Wednesday, March 20, 2024
Time:
8:00 a.m. Eastern time
Participant Dial-in:
1-833-953-2434 (U.S.) 1-412-317-5763
(International)
Replay Dial-in (Passcode
6766979):
(telephonic replay through March 27,
2024)
1-877-344-7529 (U.S.) 1-412-317-0088
(International)
Webcast: (online replay through March
20, 2025)
harrow.com
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical
company engaged in the discovery, development, and
commercialization of innovative ophthalmic pharmaceutical products
for the North American market. Harrow helps eyecare professionals
preserve the gift of sight by making its comprehensive portfolio of
prescription and non-prescription pharmaceutical products
accessible and affordable to millions of patients each year. For
more information about Harrow, please visit harrow.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240305397352/en/
Jamie Webb Director of Communications and Investor Relations
jwebb@harrowinc.com 615-733-4737
Harrow (NASDAQ:HROW)
Historical Stock Chart
From Apr 2024 to May 2024
Harrow (NASDAQ:HROW)
Historical Stock Chart
From May 2023 to May 2024
